Purchase Order HHSF223201610603P
Award Date 9/16/16
Potential Completion Date 1/31/17
Potential Value $149K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
8(a) Sole Source
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Labor Hours
Place of Performance
Silver Spring, MD 20910, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $9,388,620.00 firm fixed price definitive contract awarded by the Food and Drug Administration (FDA) to Strategi Consulting, LLC, a small disadvantaged, woman-owned business. The objective is to provide continuous data reconciliation, ad-hoc reporting, and analytics capabilities to support the FDA's ethics program. The contract does not have a set-aside designation and has an ultimate completion date of May 23, 2030. Strategi Consulting holds several significant federal contract...
- This is a definitive Time and Materials contract awarded by the Department of Health and Human Services (HHS) Food and Drug Administration (FDA) to Strategi Consulting, LLC, a small, minority-owned, 8(a) certified consulting firm based in the Washington D.C. metro area. The contract, valued at $905,551.49, is for the Division of Ethics and Integrity (DEI) 2018-2019 Filing Cycle Support. It was awarded as an 8(a) sole source contract, allowing the FDA to directly award the work to Strategi...
- This federal contract award to Strategi Consulting, LLC is a Definitive Contract valued at $4,497,672.80 for OEI ANALYTICS & DECISION SUPPORT services. The contract is a Time and Materials type awarded by the Food and Drug Administration (FDA), a civilian agency. The contract is set aside for 8(a) Small Businesses and has a period of performance through May 23, 2025. Strategi Consulting is a certified HUBZone, woman-owned, minority-owned, and small disadvantaged business that specializes...
- This federal contract award was made by the Food and Drug Administration (FDA) to Strategi Consulting, LLC, a certified HUBZone, women-owned, minority-owned, and small disadvantaged business. The $184,395.04 contract is for DEI Business and Requirements Analysis services, and was awarded as an 8(a) Sole Source set-aside contract. Strategi Consulting is a strategy and technology consulting firm with expertise in providing advanced technological solutions to federal agencies across defense and...
- The Food and Drug Administration awarded a $3.9M labor-hour contract to Strategamy LLC, a small, minority-owned business certified under the SBA's 8(a) Program, for the Food Applications Regulatory Management (FARM) Development Modernization and Enhancement (DME) initiative. This 8(a) sole source set-aside contract, awarded on September 18, 2023, with a completion date of September 28, 2025, will be performed in Berwyn Heights, Maryland. Strategamy LLC, registered in the System for Award...
- The federal contract award was issued by the Food and Drug Administration (FDA), a civilian agency, to DRT Strategies, Inc., a minority-owned, woman-owned small business. The contract, valued at $942,163.80, is for Office of Computational Science Program and Project Management and Coordination Support. This is a Delivery Order contract with a labor hours pricing type. The contract has no set-aside designation and supports the FDA's mission through IT program and project management, data...
- This is a federal contract award from the Food and Drug Administration (FDA), a civilian agency, to DRT Strategies, Inc., a small disadvantaged and woman-owned business. The contract is for $1,499,752.54 to provide enterprise project management support services. It is a delivery order under a competitive 8(a) set-aside contract, which means it is reserved for small businesses owned by socially and economically disadvantaged individuals. DRT Strategies has a track record of supporting IT...
- This is a competitive 8(a) set-aside federal contract award to DRT Strategies, Inc., a minority-owned, woman-owned, and small disadvantaged business, by the Food and Drug Administration (FDA), a civilian agency. The contract, valued at $649,741.72, is for project management services to support the FDA's Long-Term Monitoring and Oversight of Bioresearch Monitoring (LTMB) Systems Portfolio. DRT Strategies holds several existing indefinite-delivery, indefinite-quantity (IDIQ) contracts with the...
- This federal contract award was made by the Food and Drug Administration (FDA), a civilian agency, to DRT Strategies, Inc., a woman-owned small business. The contract, valued at $580,512.26, is a delivery order under the 8(a) Streamlined Technology Acquisition Resources for Services (8(a) STARS II) Government-Wide Acquisition Contract (GWAC). It is for project management, test, and analyst support services. The contract does not have a set-aside designation. DRT Strategies, Inc. is a...
- The U.S. Food and Drug Administration (FDA) awarded a $2.24 million firm fixed-price delivery order to Netimpact Strategies Inc., a woman-owned small business and SBA-certified 8(a) participant, for EPLC Enterprise Support services. The contract was awarded on June 3, 2019, as an 8(a) sole source set-aside with performance completion targeted for June 9, 2020. Work will be performed at the FDA's Silver Spring, Maryland facility. This delivery order falls under the 8a Streamlined Technology...